Health Canada grants approval for StemCells’ Phase II trial for cervical spinal cord injury

Posted byclientekdevPosted instem cell research

http://clinicaltrials.pharmaceutical-business-review.com/news/health-canada-grants-approval-for-stemcells-phase-ii-trial-for-cervical-spinal-cord-injury-190615-4604936

Health Canada has granted approval for StemCells to expand its Phase II clinical trial (Pathway Study) to evaluate the efficacy of company’s HuCNS-SC platform technology for chronic cervical spinal cord injury. The Phase II Pathway Study’s primary efficacy outcome is the change in motor strength of the…